By Denny Jacob
Organon shares tumbled 18% in premarket trading after the company cut its dividend and issued weaker quarterly results compared with the prior year.
Shares were trading around $10.60. The stock was down 13% on the year as of Wednesday's close.
The Jersey City, N.J., pharmaceutical company cut its quarterly dividend to 2 cents a share, down from the prior 28 cents a share. Chief Executive Kevin Ali said the company reset its capital-allocation priorities to accelerate its progress toward deleveraging.
Organon logged net income of $87 million on revenue of $1.51 billion in the first quarter, down from $201 million in net income on $1.62 billion in revenue in the prior-year period.
Write to Denny Jacob at denny.jacob@wsj.com
(END) Dow Jones Newswires
May 01, 2025 09:09 ET (13:09 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.